Prp19/CDC5L is implicated in cell cycle regulation, mitotic checkpoint control, and DNA repair 7-10, linking it to cancer pathogenesis, as evidenced in non-small cell lung cancer, hepatocellular carcinoma, and colorectal cancer 11-14. Here, CDC5L is linked to hepatocellular carcinoma.